Related Experiment Video
Updated: Sep 11, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Recurrent Heart Failure From Fulminant Giant Cell Myocarditis Following COVID-19 Infection Requiring Heart
Alan Amedi1, Jay N Patel2, Zachary Brennan1
1Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Insights
Giant cell myocarditis (GCM) is a rare, aggressive heart condition. Early diagnosis and treatment, including mechanical support, are crucial for improving outcomes in patients with this severe form of myocarditis.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Giant cell myocarditis (GCM) is a rare, rapidly progressive inflammatory cardiomyopathy.
- Characterized by T cell-mediated myocardial destruction, GCM presents diagnostic challenges and poor outcomes without prompt intervention.
Observation:
- A 46-year-old woman with recent COVID-19 developed flulike symptoms and dyspnea, rapidly progressing to cardiogenic shock.
- Mechanical circulatory support with venoarterial extracorporeal membrane oxygenation was initiated.
- Endomyocardial biopsy confirmed fulminant necrotizing myocarditis, leading to immunosuppressive therapy.
Findings:
- Despite initial treatment and discharge, the patient experienced recurrent shock, necessitating reinitiation of mechanical support.
- Orthotopic heart transplantation was ultimately performed.
- Explanted heart pathology definitively diagnosed Giant Cell Myocarditis.
Implications:
- GCM can mimic other myocarditis presentations, highlighting the necessity of endomyocardial biopsy for accurate diagnosis.
- This case emphasizes the potential for a fulminant clinical course in GCM.
- Early recognition, aggressive immunosuppression, and timely mechanical support are vital for managing GCM.
Background:
Giant cell myocarditis (GCM) is a rare, rapidly progressive inflammatory cardiomyopathy marked by T cell-mediated myocardial destruction. Early diagnosis is difficult, and outcomes are poor without aggressive treatment.
Case Summary:
A 46-year-old woman with recent COVID-19 presented with flulike symptoms and dyspnea. She rapidly decompensated into cardiogenic shock, requiring venoarterial extracorporeal membrane oxygenation. Endomyocardial biopsy revealed fulminant necrotizing myocarditis, prompting treatment with immunosuppressants. She was decannulated and discharged but returned 2 weeks later in shock, again requiring venoarterial extracorporeal membrane oxygenation. She ultimately underwent orthotopic heart transplantation. Explanted pathology confirmed GCM.
Discussion:
GCM can mimic other forms of myocarditis but requires biopsy for diagnosis. This case underscores the fulminant course of GCM, the utility of early mechanical support, and the importance of prompt recognition.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Myocarditis I: Introduction

